Showing 1 - 13 results of 13 for search 'E.V. Derkach', query time: 0.10s Refine Results
  1. 1
    Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients

    Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients by E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION

    PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION by M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE

    COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE by V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE

    COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE by V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Drugs influencing on PCSK9 activity: modelling of efficacy in patients who had myocardial infarction with uncontrolled dyslipidemia

    Drugs influencing on PCSK9 activity: modelling of efficacy in patients who had myocardial infarction with uncontrolled dyslipidemia by V. I. Ignatyeva, A. V. Kontsevaya, O. M. Drapkina, E. V. Derkach

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY

    METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY by N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome

    Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome by O. I. Ivakhnenko, E. V. Derkach, V. S. Krysanova, A. D. Ermolaeva, K. A. Kokushkin

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    ANALYSIS OF THE COST OF THE DISEASE - PROBLEMS AND SOLUTIONS

    ANALYSIS OF THE COST OF THE DISEASE - PROBLEMS AND SOLUTIONS by V.V. Omel'yanovskii, M.V. Avksent'eva, E.V. Derkach, N.D. Sveshnikova

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    ANALYSIS OF THE COST OF THE DISEASE - PROBLEMS AND SOLUTIONS

    ANALYSIS OF THE COST OF THE DISEASE - PROBLEMS AND SOLUTIONS by V.V. Omel'yanovskii, M.V. Avksent'eva, E.V. Derkach, N.D. Sveshnikova

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups

    The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups by E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting

    Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting by E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  12. 12
    SOCIAL AND ECONOMIC BURDEN OF FIVE NATURAL FOCAL INFECTIONS IN THE RUSSIAN FEDERATION

    SOCIAL AND ECONOMIC BURDEN OF FIVE NATURAL FOCAL INFECTIONS IN THE RUSSIAN FEDERATION by A. E. Platonov, N. A. Avksentyev, M. V. Avksentyeva, E. V. Derkach, O. V. Platonova, A. V. Titkov, N. M. Kolyasnikova

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  13. 13
    DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY

    DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY by M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: